Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 9, 2026PharmacoEconomicsOpen Access

A Systematic Review of the Economic Burden of Prostate Cancer: Direct and Indirect Cost Perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJosep DarbàMAMeritxell AscanioARAntonio Rodríguez

Discussion

Loading...

Member takes

Overview

A systematic review reveals high economic costs of prostate cancer, suggesting early detection and equitable access can mitigate expenses.

Key Points

  • The aim is to evaluate the economic burden of prostate cancer from both direct and indirect cost perspectives.
  • Conducted a systematic review of existing literature on prostate cancer costs.
  • Analyzed economic impacts associated with various stages of the disease.
  • Examined effects of early detection and treatment approaches.
  • Prostate cancer imposes significant costs on healthcare systems, especially in advanced stages.
  • Early detection and equitable access may reduce these economic burdens.
  • Emerging diagnostics and minimally invasive interventions could further influence cost outcomes.

Cite This Study

Darbà et al. (2026) studied this question.

synapsesocial.com/papers/698979d9f0ec2af6756e7c99https://doi.org/10.1007/s40273-026-01594-4
View Full Paper
Ask AI
Bookmark
Share